Associated Papers
Plasma myeloperoxidase interactions with cadmium, lead, arsenic, and selenium and their impact on chronic kidney disease.
Chen HH et al.
Ecotoxicology and Environmental Safety, 2025
Genetic predisposition to acute kidney injury--a systematic review.
Vilander LM et al.
Bmc Nephrology, 2015
Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes.
Perianayagam MC et al.
Kidney International, 2012
Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
Wainstein RV et al.
Clinical Biochemistry, 2010
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
Videm V et al.
Coronary Artery Disease, 2009
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
Chen SN et al.
Bmc Medical Genetics, 2009
19878569 (PubMed )
Supplement: 1471-2350-10-111-S1.pdf
Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease.
Zhong C et al.
Genetics and Molecular Biology, 2009
Myeloperoxidase gene sequence variations are associated with low-density-lipoprotein characteristics.
Dolley G et al.
Journal of Human Genetics, 2008
A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.
Harris SE et al.
Bmc Genetics, 2007
17601350 (PubMed )
Supplement: 1471-2156-8-43-S1.doc
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Chevrier I et al.
Atherosclerosis, 2006
Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
Chevrier I et al.
Pharmacogenetics, 2003
Select a paper to view details